Does anyone have any best practices around ensuring 3-mL syringes are used to prepare 3-mL NICU doses?

We’ve had incidents of 3-mL doses dispensed in 5-mL syringes. The ordered rate was less than 0.1 mL/hr. Because the Alaris syringe pump cannot deliver a flow rate lower than 0.1 mL/hr from a 5-mL syringe, the doses had to be sent back to be prepared a second time in 3-mL syringes.

We are thinking about including syringes as components to be scanned when Dispense Prepping NICU mixtures in Epic but are running into some workflow challenges with that.

Hello everyone! We are wondering what other institutions that use CADDs for epidurals are doing due to the current CADD shortage. We are trying to switch to bags but can't find the correct tubing. Would love to hear if other institutions are running into the same problem and how they are managing this shortage.

Thank you so much!
Christine

To all,

I received a request regarding multiple use, commercially produced eye drops and the assigned beyond use date should be 28 days. I have seen the data regarding expiration of multiple use eye drops when administered to multiple patients in the healthcare settings.

Practice Setting: Long term psychiatric hospitalization in the State of WA. Most patients are admitted greater than 30 days. Not currently a CMS certified facility.

Current Practice for dispensing commercially prepared eye drops:

Hello,
Has anyone tried any systems-based solutions to preventing or monitoring for extravasations (to irritants or vesicants in all inpatient and oncology/infusion settings, infusion/nicu/pedi/ICU etc)?

We are wondering if anything like antidotes, nursing instructions, links to protocols, etc could be programmed into our Epic and Beacon system to prevent or increase awareness of drugs that are at high risk of extravasation, but we are wondering if anyone has had success with any other system based solution before we dedicate resources into this idea.

Thanks!

Hello,
Has anyone tried any systems-based solutions to preventing or monitoring for extravasations (to irritants or vesicants in all inpatient and oncology/infusion settings, infusion/nicu/pedi/ICU etc)?

We are wondering if anything like antidotes, nursing instructions, links to protocols, etc could be programmed into our Epic and Beacon system to prevent or increase awareness of drugs that are at high risk of extravasation, but we are wondering if anyone has had success with any other system based solution before we dedicate resources into this idea.

Thanks!

Our organization is working to establish an interdisciplinary EHR Alert committee, and looking to learn from others regarding what has worked. Please take a minute to answer this short survey. Results will be shared.

https://forms.gle/ZQcmBsdVzaxgjAZg9

Thank you.

Seeking to learn how other organizations with Cerner EHR have designed EHR alert settings for "therapeutic duplication" for various user roles. Could you describe your strategy for optimizing these alerts to trigger for clinically inappropriate duplications? Do the settings differ for medical staff vs. pharmacists?

For organizations that still use chloral hydrate for pediatric procedural sedation, what procedures/policies/workflow (if any) do you have regarding appropriate storage and handling? It's not on the NIOSH list given it's unique regulatory status, but IARC classifies it as a potential human carcinogen. Did you perform an assessment of risk?

Hello,

Curious if any organizations have experience with removing meperidine from formulary entirely or do most still keep for restricted indications (for example: post-anesthesia shivering)?

Thanks so much for any feedback you'd be willing to share!

Does ISMP/FDA guidance to avoid use of the "TPA" abbreviation apply to order synonyms in your organization? Does anyone allow use of the synonym "TPA" to direct to alteplase orders within their hospital information system?

Thank you!

Wyndie Tse
City of Hope